Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G

Por Kailayangiri, Sareetha, Altvater, Bianca, Spurny, Christian, Jamitzky, Silke, Schelhaas, Sonja, Jacobs, Andreas H., Wiek, Constanze, Roellecke, Katharina, Hanenberg, Helmut, Hartmann, Wolfgang, Wiendl, Heinz, Pankratz, Susann, Meltzer, Jutta, Farwick, Nicole, Greune, Lea, Fluegge, Maike, Rossig, Claudia
Publicado no Oncoimmunology (2016)